Grant of US Patent

27 June 2019

Directa Plus plc

("Directa Plus" or the "Company")

US Patent Grant

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce the grant of a key patent, relating to the Company's unique manufacturing process, by the United States Patent and Trademark Office.

The new US patent covers Directa Plus' unique process for manufacturing graphene nanoplatelets using a water-based exfoliation technology. The process is sustainable and environmentally friendly as a result of using no chemicals, solvents or surfactants and generating zero waste. The manufacturing process allows the Company to engineer a wide range of particle morphologies that can be tailored to the particular requirements of end-user customers. In addition, the 100 per cent production yield means that Directa Plus can manufacture products in large volumes at attractive prices. This provides a significant competitive advantage, enabling the Company to integrate effectively and quickly with customers' large supply chains.

Commenting on the grant, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This grant represents a key development in launching our products into the United States. The sustainable nature of our production process, using no chemicals, is proving to be an attractive point of difference in negotiations with large US companies."

For further information please visit http://www.directa-plus.com/ or contact:

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.